MRI findings in the central nervous system PCM | RRTM
1. Peçanha PM, Peçanha-Pietrobom PM, Grão-Velloso TR, et al. Paracoccidioidomycosis: what we know and what is new in epidemiology, diagnosis, and treatment. J FungiBasel). 2022;8(10):1098. doi:10.3390/jof8101098
2. Canteros CE. Paracoccidioidomicosis: crónica de una enfermedad olvidada [Paracoccidioidomycosis: chronicle of a neglected disease]. Medicina. 2018;78(3):180–184. Spanish.
3. Travassos LR, Taborda CP, Colombo AL. Treatment options for paracoccidioidomycosis and new strategies investigated. Expert Rev Anti Infect Ther. 2008;6(2):251–262. doi:10.1586/14787210.6.2.251
4. Shikanai-Yasuda MA, Mendes RP, Colombo AL, et al. Brazilian guidelines for the clinical management of paracoccidioidomycosis. Rev Soc Bras Med Trop. 2017;50(5):715–740. doi:10.1590/0037-8682-0230-2017
5. Turissini DA, Gomez OM, Teixeira MM, McEwen JG, Matute DR. Species boundaries in the human pathogen Paracoccidioides. Fungal Genet Biol. 2017;106:9–25. doi:10.1016/j.fgb.2017.05.007
6. Terçarioli GR, Bagagli E, Reis GM, et al. Ecological study of Paracoccidioides brasiliensis in soil: growth ability, conidia production and molecular detection. BMC Microbiol. 2007;7(1):92. doi:10.1186/1471-2180-7-92
7. Marques-da-silva SH, Rodrigues AM, de Hoog GS, Silveira-Gomes F, Camargo ZP. Occurrence of Paracoccidioides lutzii in the Amazon region: description of two cases. Am J Trop Med Hyg. 2012;87(4):710–714. doi:10.4269/ajtmh.2012.12-0340
8. de Oliveira VF, Magri MMC, Levin AS, Silva GD. Systematic review of neuroparacoccidioidomycosis: the contribution of neuroimaging. Mycoses. 2023;66(2):168–175. doi:10.1111/myc.13525
9. Silva Ferreira C, de Castro Ribeiro EM, Miranda Goes A, Mello Silva BD. Current strategies for diagnosis of paracoccidioidomycosis and prospects of methods based on gold nanoparticles. Future Microbiol. 2016;11:973–985. doi:10.2217/fmb-2016-0062
10. Gasparetto EL, Liu CB, de Carvalho Neto A, Rogacheski E. Central nervous system paracoccidioidomycosis: imaging findings in 17 cases. J Comput Assist Tomogr. 2003;27(1):12–17. doi:10.1097/00004728-200301000-00003
11. Franco M, Montenegro MR, Mendes RP, Marques SA, Dillon NL, Mota NG. Paracoccidioidomycosis: a recently proposed classification of its clinical forms. Rev Soc Bras Med Trop. 1987;20(2):129–132. doi:10.1590/s0037-86821987000200012
12. Brummer E, Castaneda E, Restrepo A. Paracoccidioidomycosis: an update. Clin Microbiol Rev. 1993;6(2):89–117. doi:10.1128/CMR.6.2.89
13. de Almeida SM. Central nervous system paracoccidioidomycosis: an overview. Braz J Infect Dis. 2005;9(2):126–133. doi:10.1590/s1413-86702005000200002
14. Benard G. An overview of the immunopathology of human paracoccidioidomycosis. Mycopathologia. 2008;165(4–5):209–221. doi:10.1007/s11046-007-9065-0
15. Benard G, Romano CC, Cacere CR, Juvenale M, Mendes-Giannini MJ, Duarte AJ. Imbalance of IL-2, IFN-gamma and IL-10 secretion in the immunosuppression associated with human paracoccidioidomycosis. Cytokine. 2001;13(4):248–252. doi:10.1006/cyto.2000.0824
16. Oliveira SJ, Mamoni RL, Musatti CC, Papaiordanou PM, Blotta MH. Cytokines and lymphocyte proliferation in juvenile and adult forms of paracoccidioidomycosis: comparison with infected and non-infected controls. Microbes Infect. 2002;4(2):139–144. doi:10.1016/s1286-4579(01)01521-0
17. de Castro LF, Ferreira MC, da Silva RM, Blotta MH, Longhi LN, Mamoni RL. Characterization of the immune response in human paracoccidioidomycosis. J Infect. 2013;67(5):470–485. doi:10.1016/j.jinf.2013.07.019
18. de Almeida SM, Queiroz-Telles F, Teive HA, Ribeiro CE, Werneck LC. Central nervous system paracoccidioidomycosis: clinical features and laboratorial findings. J Infect. 2004;48(2):193–198. doi:10.1016/j.jinf.2003.08.012
19. Shankar J, Restrepo A, Clemons KV, Stevens DA. Hormones and the resistance of women to paracoccidioidomycosis. Clin Microbiol Rev. 2011;24(2):296–313. doi:10.1128/CMR.00062-10
20. Martinez R. New trends in paracoccidioidomycosis epidemiology. J Fungi. 2017;3(1):1. doi:10.3390/jof3010001
21. Magalhães AC, Bacheschi LA, Caramelli P, et al. Paracoccidioidomicose do sistema nervoso central: estudo de cinco casos por ressonância magnética [Paracoccidioidomycosis of the central nervous system: study of 5 cases by magnetic resonance]. Rev Hosp Clin Fac Med Sao Paulo. 1993;48(2):94–97. Portuguese.
22. Franco M, Mendes RP, Moscardi-Bacchi M, Rezkallah-Iwasso M, Montenegro MR. Paracoccidioidomycosis. Baillières Clinl Trop Med Commun Dis. 1989;4:185–220.
23. Rosa Júnior M, Baldon IV, Amorim AFC, et al. Imaging paracoccidioidomycosis: a pictorial review from head to toe. Eur J Radiol. 2018;103:147–162. doi:10.1016/j.ejrad.2018.03.026
24. Francesconi F, Francesconi Do Valle AC, Silva MT, Costa RL, Carregal E, Talhari S. International issues: meningoencephalitis due to Paracoccidioides brasiliensis. Neurology. 2008;71(21):e65–e67. doi:10.1212/01.wnl.0000335266.60637.c3
25. Elias J
26. Martinez R. Epidemiology of paracoccidioidomycosis. Rev Inst Med Trop Sao Paulo. 2015;19(Suppl 19):11–20. doi:10.1590/S0036-46652015000700004
27. de Almeida Jr. JN Jr, Peçanha-Pietrobom PM, Colombo AL. Paracoccidioidomycosis in immunocompromised patients: a literature review. J Fungi. 2018;5(1):2. doi:10.3390/jof5010002
28. Pereira FV, Alves KPO, Altemani AM, Reis F. Disseminated paracoccidioidomycosis with skull and mandible involvement in a heart transplant recipient. Rev Soc Bras Med Trop. 2022;55:e0110. doi:10.1590/0037-8682-0110-2022
29. Gardizani TP, Della Coletta AM, Romagnoli GG, et al. 43 kDa glycoprotein (gp43) from Paracoccidioides brasiliensis induced IL-17A and PGE2 production by human polymorphonuclear neutrophils: involvement of TLR2 and TLR4. J Immunol Res. 2019;2019:1790908. doi:10.1155/2019/1790908
30. de Almeida SM, Queiroz-Telles F, Doi EM, Ono M, Werneck LC. Anti-gp43 antibodies in the cerebrospinal fluid of patients with central nervous system involvement by paracoccidioidomycosis. Am J Clin Pathol. 2002;118(6):864–868. doi:10.1309/H2LU-UX28-7QHN-V5H3
31. Salina MA, Shikanai-Yasuda MA, Mendes RP, Barraviera B, Mendes Giannini MJ. Detection of circulating Paracoccidioides brasiliensis antigen in urine of paracoccidioidomycosis patients before and during treatment. J Clin Microbiol. 1998;36(6):1723–1728. doi:10.1128/JCM.36.6.1723-1728.1998
32. Góes AM, Silva LSS, Araújo AS, Cruz SG, Siqueira WC, Pedroso ERP. Paracoccidioidomicose (doença de Lutz-Splendore-Almeida): etiologia, epidemiologia e patogênese [Paracoccidioidomycosis disease (Lutz-Splendore-Almeida): etiology, epidemiology, and pathogenesis]. Rev Med Minas Gerais. 2014;24(1):61–66.
33. Filho GB. Bogliolo – Patologia [Bogliolo – Pathology].
34. Palmeiro M, Cherubini K, Yurgel LS. Paracoccidioidomicose – revisão da Literatura [Paracoccidioidomycosis – Literature Review]. Sci Med. 2005;15(4):274–278.
35. Rodacki MA, De Toni G, Borba LA, Oliveira GG. Paracoccidioidomycosis of the central nervous system: CT findings. Neuroradiology. 1995;37(8):636–641. doi:10.1007/BF00593377
36. Rosa Júnior M, Amorim AC, Baldon IV, et al. Paracoccidioidomycosis of the central nervous system: CT and MR imaging findings. Am J Neuroradiol. 2019;40(10):1681–1688. doi:10.3174/ajnr.A6203
37. de Morais RQ, Salomon MFB, Corbiceiro WCH, de Melo ASA, Corrêa DG. Imaging contribution for the diagnosis of disseminated paracoccidioidomycosis. Int J Infect Dis. 2020;101:206–209. doi:10.1016/j.ijid.2020.09.1482
38. Barreto MM, Marchiori E, Amorim VB, et al. Thoracic paracoccidioidomycosis: radiographic and CT findings. Radiographics. 2012;32(1):71–84. doi:10.1148/rg.321115052
39. Costa AN, Benard G, Albuquerque AL, et al. The lung in paracoccidioidomycosis: new insights into old problems. Clinics. 2013;68(4):441–448. doi:10.6061/clinics/2013(04)02
40. da Silva CE, Cordeiro AF, Gollner AM, Cupolilo SM, Quesado-Filgueiras M, Curzio MF. Paracoccidioidomicose do sistema nervoso central: relato de caso [Paracoccidioidomycosis of the central nervous system: case report]. Arq Neuropsiquiatr. 2000;58(3A):741–747. Portuguese. doi:10.1590/s0004-282×2000000400024
41. Reis F, Collier PP, Souza TF, et al. Neuroparacoccidioidomycosis (NPCM): magnetic resonance imaging (MRI) findings. Mycopathologia. 2013;175(1–2):181–186. doi:10.1007/s11046-012-9607-y
42. da Rocha AJ, Maia AC
43. Faria AV, Dabus GC, Zanardi VA, Cendes F. Proton magnetic resonance spectroscopy and magnetic resonance imaging findings in a patient with central nervous system paracoccidioidomycosis. J Neuroimaging. 2004;14(4):377–379. doi:10.1177/1051228404267053
44. Rosa-JÚnior M, Grenfell MLR, Peçanha PM. Hippocampal sclerosis in paracoccidioidomycosis. Arq Neuropsiquiatr. 2020;78(6):384. doi:10.1590/0004-282X20200015
45. Currie S, Fatania K, Matthew R, et al. A comprehensive clinical review of adult-type diffuse glioma incorporating the 2021 World Health Organization classification. Neurographics. 2022;12:43–70. doi:10.3174/ng.2100034
46. Hsu CC, Watkins TW, Kwan GN, Haacke EM. Susceptibility-weighted imaging of glioma: update on current imaging status and future directions. J Neuroimaging. 2016;26(4):383–390. doi:10.1111/jon.12360
47. Abud LG, Queiroz RM, Abud TG. Concomitant pulmonary and central nervous system paracoccidioidomycosis with cerebellar abscess. Rev Soc Bras Med Trop. 2015;48(6):789. doi:10.1590/0037-8682-0259-2015
48. Ebisu T, Tanaka C, Umeda M, et al. Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. Magn Reson Imaging. 1996;14(9):1113–1116. doi:10.1016/s0730-725x(96)00237-8
49. Riechelmann RS, Rodrigues LH, Avelar TM, et al. Isolated neuroparacoccidioidomycosis as a pseudotumoral lesion in the absence of systemic disease. Surg Neurol Int. 2020;11:151. doi:10.25259/SNI_224_2020
50. Toh CH, Wei KC, Chang CN, et al. Differentiation of pyogenic brain abscesses from necrotic glioblastomas with use of susceptibility-weighted imaging. Am J Neuroradiol. 2012;33(8):1534–1538. doi:10.3174/ajnr.A2986
51. Pal D, Bhattacharyya A, Husain M, Prasad KN, Pandey CM, Gupta RK. In vivo proton MR spectroscopy evaluation of pyogenic brain abscesses: a report of 194 cases. Am J Neuroradiol. 2010;31(2):360–366. doi:10.3174/ajnr.A1835
52. Duarte SBL, Oshima MM, Mesquita JVDA, Do Nascimento FBP, de Azevedo PC, Reis F. Magnetic resonance imaging findings in central nervous system cryptococcosis: comparison between immunocompetent and immunocompromised patients. Radiol Bras. 2017;50(6):359–365. doi:10.1590/0100-3984.2016.0017
53. Pedro RDJ, Branchini ML, de Lucca RS, da Silveira ML, Facure NO, Amato Neto V. Paracoccidioidomicose de sistema nervoso central. A propósito de dois casos [Paracoccidioidomycosis of the central nervous system. Apropos of 2 cases]. Rev Inst Med Trop Sao Paulo. 1980;22(5):269–274. Portuguese.
54. Lorenzoni PJ, Chang MR, Paniago AM, Salgado PR. Meningite paracoccidioidomicótica: relato de caso [Paracoccidioidomycosis meningitis: case report]. Arq Neuropsiquiatr. 2002;60(4):1015–1018. Portuguese. doi:10.1590/s0004-282×2002000600025
55. Roozpeykar S, Azizian M, Zamani Z, et al. Contrast-enhanced weighted-T1 and FLAIR sequences in MRI of meningeal lesions. Am J Nucl Med Mol Imaging. 2022;12(2):63–70.
56. Corrêa DG, de Souza SR, Freddi TAL, et al. Imaging features of neurosyphilis. J Neuroradiol. 2023;50(2):241–252. doi:10.1016/j.neurad.2023.01.003
57. Kandemirli SG, Bathla G. Neuroimaging findings in rheumatologic disorders. J Neurol Sci. 2021;427:117531. doi:10.1016/j.jns.2021.117531
58. França AFEDC, Velho PENF, Reis F. Spinal cord and cutaneous involvement in paracoccidioidomycosis. Rev Soc Bras Med Trop. 2021;54:e0115. doi:10.1590/0037-8682-0115-2021
59. Almeida TAL, Mallmann AB, Crusius PS, et al. Medullary paracoccidioidomycosis treated successfully with oral itraconazole. Arquivos Brasileiros de Neurocirurgia. 2016;35(04):352–356. doi:10.1055/S-0035-1571267
60. Do Valle AC, Skacel M, Costa RL, Ribeiro CT, Montagna NA, da Cruz LC. A case report of intraspinal paracoccidioidomycosis. Rev Inst Med Trop Sao Paulo. 1998;40(3):203–207. doi:10.1590/s0036-46651998000300014
61. Pacheco RA, Arruda WO, Hunhevicz SC, Tsubouchi MH, Torres LF. Thoracic intraspinal paracoccidioidomycosis. Case report. Arq Neuropsiquiatr. 1996;54(3):474–478. doi:10.1590/s0004-282×1996000300018